Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Dr Reddys launches generic nausea drug in US

      Dr Reddy's launches generic nausea drug in US

      Ruby Khatun Khatun27 March 2018 10:31 AM IST
      New Delhi: Dr Reddy's Laboratories said it has launched Palonosetron Hydrochloride Injection, used in treating acute nausea and vomiting, in the US...
      NCLT approves demerger of Strides Shasun and SeQuent Scientific API busines

      NCLT approves demerger of Strides Shasun and SeQuent Scientific API busines

      Ruby Khatun Khatun27 March 2018 10:15 AM IST
      New Delhi: National Company Law Tribunal (NCLT) has approved the composite scheme involving demerger of Commodity API business of Strides and Human...
      We support Make in India for quality medical devices; reasonable pricing: MTaI

      We support Make in India for quality medical devices; reasonable pricing: MTaI

      Ruby Khatun Khatun27 March 2018 10:00 AM IST
      New Delhi: Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant...
      Roches Tecentriq cocktail adds to lung cancer survival success

      Roche's Tecentriq cocktail adds to lung cancer survival success

      Ruby Khatun Khatun27 March 2018 9:45 AM IST
      ZURICH: Roche’s Tecentriq immunotherapy combined with other drugs boosted lung cancer patients’ survival versus an older cocktail, the Swiss company...
      US jury orders AbbVie to pay 3 million dollar in AndroGel retrial

      US jury orders AbbVie to pay 3 million dollar in AndroGel retrial

      Ruby Khatun Khatun27 March 2018 9:30 AM IST
      NEW YORK: A U.S. jury ordered AbbVie Inc to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone...
      Fortis Acquisition boils down to TPG verus IHH

      Fortis Acquisition boils down to TPG verus IHH

      Ruby Khatun Khatun26 March 2018 5:40 PM IST
      New Delhi: The deal for Fortis seems to be making strides with investors from various angles coming and putting forward their investment strategies....
      Police arrest 3 medical shop owners for allegedly selling addictive cough syrup

      Police arrest 3 medical shop owners for allegedly selling addictive cough syrup

      Ruby Khatun Khatun26 March 2018 4:41 PM IST
      Chennai: Three medical shop owners were arrested by police in Chintadripet for allegedly selling addictive cough syrup of a particular brand without...
      Metropolis Healthcare plans to add 800 centres, 10 labs by FY19 end

      Metropolis Healthcare plans to add 800 centres, 10 labs by FY19 end

      Ruby Khatun Khatun26 March 2018 11:00 AM IST
      New Delhi: Diagnostic chain Metropolis Healthcare is planning to add 800 collection centers and around 10 laboratories by the end of next fiscal, a...
      Bal Pharma acquires Golden Drugs Pvt Ltd

      Bal Pharma acquires Golden Drugs Pvt Ltd

      Ruby Khatun Khatun26 March 2018 10:30 AM IST
      New Delhi: Bal Pharma Ltd has informed BSE that it has acquired 100 percent shareholding, management control and ownership of M/s Golden Drugs Private...
      Sandoz receives positive CHMP opinion for proposed biosimilar infliximab

      Sandoz receives positive CHMP opinion for proposed biosimilar infliximab

      Ruby Khatun Khatun26 March 2018 10:00 AM IST
      Sandoz, a Novartis division and the global leader in biosimilars, announced that the Committee for Medicinal Products for Human Use (CHMP) of the...
      GSK pulls out of 20 billion race for Pfizer consumer assets

      GSK pulls out of 20 billion race for Pfizer consumer assets

      Ruby Khatun Khatun26 March 2018 9:30 AM IST
      LONDON: GlaxoSmithKline (GSK) has withdrawn from the race to buy Pfizer's consumer healthcare business, the British company said endangering an...
      FDA moves to limit ingredients for bulk drug compounding

      FDA moves to limit ingredients for bulk drug compounding

      Ruby Khatun Khatun25 March 2018 10:30 AM IST
      BOSTON: The U.S. Food and Drug Administration took steps to restrict what pharmaceutical ingredients large compounding pharmacies can use to...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok